I would say that the pharmaceutical industry is hyper-competitive from a global perspective.

The pricing of a pharmaceutical product is opaque and frustrating, especially for patients.

We recognize the significant burden on patients from continued, rising insurance premiums and being forced increasingly to pay the full list price for medicines at the pharmacy counter.

My experiences with gender bias are probably the norm. What I found was that expectations of women were simply lower, and this resulted in being overlooked for certain opportunities.

The pharma pricing system was not built on the idea of consumer engagement. It was built... on market efficiencies. It was not built on the premise of consumerism.

There is simply no substitute for hard work when it comes to achieving success.